Latest Market Updates News

DEXUS has announced an estimated ordinary distribution of AUD 0.193 per unit for the six months ending December 2025, marking a steady income stream for investors ahead of the new year.

GrainCorp announces the sale of its Canadian joint venture GrainsConnect to Parrish & Heimbecker for C$150 million, alongside a trading update revealing lower expected grain receivals in Australia’s 2025-26 winter harvest.

Fiducian Group’s subsidiary Fiducian Investment Management Services Limited has filed a defence after ASIC initiated civil proceedings alleging misleading disclosure and compliance failures related to a managed fund.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Mayfield Group Holdings has successfully closed an oversubscribed share purchase plan, raising over $5 million against a $3 million target, prompting a pro rata scale-back for larger applications.

Black Bear Minerals has reported exceptional high-grade silver rock chip samples up to 3,100g/t outside its existing Shafter Mineral Resource in Texas, revealing promising multi-commodity potential and plans for expanded exploration.

Iress Ltd has responded to recent media speculation about a potential acquisition, clarifying it cannot confirm any deal terms while continuing discussions with multiple parties.

Cobalt Blue Holdings has significantly upgraded the economics of its Kwinana Cobalt Refinery project, driven by a sharp rebound in cobalt prices following market disruptions in the Democratic Republic of Congo. The company is advancing towards a Final Investment Decision with key permits and supply agreements in place.

Lodestar Minerals has responded to ASX queries clarifying the timing and disclosure of key assay results from its Ned’s Creek gold project and detailed the procedural steps behind its Arizona Mountain Pass rare earths acquisition.

AusQuest Limited has identified three additional high-grade magnetite prospects at its Morrisey Project in Western Australia, with premium iron grades exceeding 70% Fe and promising recovery rates. These findings enhance the project's commercial appeal as it advances under a strategic alliance with South32.

PYC Therapeutics reports sustained vision improvements in patients with Retinitis Pigmentosa type 11 treated with VP-001, showing promising safety and efficacy up to 18 months. The company plans to engage the FDA in early 2026 to finalize pivotal trial design.

Challenger Limited has provided a detailed update on APRA’s proposed capital standards, highlighting enhanced capital strength and strategic growth opportunities in the life insurance sector.